Not Tagged
Not Tagged
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
presenting our preclinical work at #ash2022 for the world s first gspt1 degrader delivered by anti-cd33 antibody. #tpd #adc #aml 
Drug inventor—Sarclisa. CSO of Orum Therapeutics. Developing dual-precision antibody-enabled targeted protein degraders. Biotech investor.